Novel peptide-antibody fusion molecule enhances SARS-CoV-2 variant neutralization
A recent study reports neutralizing efficacy for a fused peptide-antibody molecule against SARS-CoV-2, providing hope that therapeutic neutralizing antibodies may soon be available.
Starshaker Shutterstock Peptide Antibody Fusions Engineered Phage Display Exhibit Ultrapotent Broad Neutralization Image Credit Coronavirus Disease Covid 19
Source: news-medical.net